10-Q quarterly report · filed Nov 3, 2026

Alkermes plc. (ALKS) Q3 2026 10-Q Quarterly Report

Short answer

Alkermes plc. (ALKS) filed its Q3 2026 10-Q quarterly report on Nov 3, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $480M (up 21.8% year over year) with net income of $16M.

Q3 2026 key financials · XBRL

Revenue
$480M
+21.8% YoY · −3.2% QoQ
Net income
$16M
−80.3% YoY · +3150.9% QoQ
Operating margin
7.5%
EPS (diluted)
$0.10
−79.6% YoY

Source: XBRL data from the Alkermes plc. (ALKS) Q3 2026 10-Q on SEC EDGAR. USD.

Alkermes plc. Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Revenue $480.2M, up $85.9M YoY, driven by LUMRYZ addition
  • Product sales $417.3M vs $317.4M, with LUMRYZ $89.9M, best-performing product
  • LYBALVI $95.9M vs $98.2M, worst product performance, down $2.3M YoY
  • Net income $16.3M vs $82.8M, operating expenses up $139.0M and interest expense up $27.6M
  • Cash $631.3M, operating cash flow $72.9M, Avadel acquisition cash consideration $2,199.2M; existing liquidity expected sufficient 12 months

Risk Factors

  • No material changes disclosed, with risk factors incorporated by reference to the Annual Report

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other Alkermes plc. quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.